Four plasma biomarkers were noted as significantly higher in the PD group, including p-Tau (p = 0.0012), Aβ-42 (p = 0.0004), α-syn (p = 0.0390), and NfL (p = 0.0016). This evidence concerns the gene MAPT and Parkinson disease.